| Literature DB >> 25418630 |
Maximilian Kuetting1, Desiree Pott, Alexander Sedaghat, Yue Ann Ng, Sandrine Egron, Christiane Rosefort, Nikos Werner, Joerg Sachweh, Ulrich Steinseifer.
Abstract
Minimally invasive, catheter-based treatment of valvular dysfunction has become an integral part of clinical routine. As left heart valvular disease is much more common and thus commercially of interest, transcatheter solutions for the treatment of aortic and mitral valvular defects were the first to become broadly clinically available, while even today options for the right heart valve are rare. This review looks at innovative attempts at developing effective transcatheter heart valve prostheses for the pulmonary and tricuspid heart valves, details their experience and highlights those that have made their way to application in humans.Entities:
Keywords: GUCH; catheter-based therapy; pulmonary heart valve; stent frame design; transcatheter heart valves; tricuspid heart valve; valve-in-valve; valvular dysfunction
Mesh:
Year: 2014 PMID: 25418630 DOI: 10.1586/17434440.2015.985654
Source DB: PubMed Journal: Expert Rev Med Devices ISSN: 1743-4440 Impact factor: 3.166